Saturday, September 18, 2021

US court rules in favour of AZ in Symbicort patent litigation




A US court has ruled in favour of AstraZeneca (AZ) in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery over patents for asthma treatment Symbicort.

The US District Court for the Northern District of West Virginia determining that claims in AZ’s patents protecting Symbicort (budesonide/formoterol) in the US are not invalid.

AZ launched the litigation against Mylan and 3M Company in October 2018, asserting that the companies had infringed upon various US patents covering Symbicort.

Kindeva was added as a defendant in the action in July 2020, while 3M was voluntarily dismissed from the case.

In a statement, AZ said that both Mylan and Kindeva contended at trial that each asserted patent claim to Symbicort is invalid under the US patent laws.

“AstraZeneca is pleased with the Court’s decision, and we maintain full confidence in the strength of our intellectual property rights protecting Symbicort,” said Ruud Dobber, executive vice president, BioPharmaceuticals business unit, AZ.

Symbicort was initially launched in 2000 and is approved in approximately 120 countries for the treatment of asthma and/or chronic obstructive pulmonary disease (COPD).

In January 2020, AZ entered an agreement with Prasco to distribute an authorised generic version of Symbicort in the US.



Source link

Latest Articles

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...

Understand Key Account Management

INTRODUCTION: Key Account Management is the essential showcasing approach that gives a successful, useful, and rather basic technique for...

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...